Francesca Barone
Patrimonio netto: 1 M $ in data 31/08/2026
Patrimonio netto: 1 M $ in data 31/08/2026
Francesca Barone is currently Chief Scientific Officer at Candel Therapeutics, Inc. since 2022.
Former positions include Director-Laboratories at the Institute of Translational Medicine, Associate Professor at the University of Birmingham from 2010 to 2019, and Head-Experimental Medicine at Senda Biosciences, Inc. from 2019 to 2021.
Education includes doctorates from Sapienza University of Rome and King's College London.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 29/06/2026 | 77.362 ( 0,1% ) | 1 M $ | 31/08/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| CANDEL THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 01/11/2020 |
| Società | Posizione | Fine |
|---|---|---|
Senda Biosciences, Inc.
Senda Biosciences, Inc. BiotechnologyHealth Technology Develops therapeutics to treat diseases | Corporate Officer/Principal | 01/11/2021 |
University of Birmingham
University of Birmingham Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/12/2019 |
Institute of Translational Medicine | Corporate Officer/Principal | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 6 |
|---|---|
University of Birmingham
University of Birmingham Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sapienza University of Rome
Sapienza University of Rome Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
King's College London
King's College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Candel Therapeutics, Inc.
Candel Therapeutics, Inc. BiotechnologyHealth Technology Develops and distributes immunotherapies for the treatment of cancer | Health Technology |
Senda Biosciences, Inc.
Senda Biosciences, Inc. BiotechnologyHealth Technology Develops therapeutics to treat diseases | Health Technology |
Institute of Translational Medicine |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale